Massimo Falconi
Overview
Explore the profile of Massimo Falconi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
575
Citations
17467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pieterman C, Grozinsky-Glasberg S, OToole D, Howe J, Ambrosini V, Belli S, et al.
J Neuroendocrinol
. 2024 Nov;
37(1):e13468.
PMID: 39587981
Multiple Endocrine Neoplasia type 1 (MEN1) Clinical Practice Guidelines (2012) are predominantly based on expert opinion due to limited available evidence at the time, leaving room for interpretation and variation...
12.
Tacelli M, Partelli S, Falconi M, Arcidiacono P, Capurso G
United European Gastroenterol J
. 2024 Nov;
13(1):34-43.
PMID: 39540703
The incidence and prevalence of pancreatic neuroendocrine neoplasms are steadily increasing. These tumors are highly heterogeneous, with treatment options ranging from observation to surgery, and various medical therapies. The choice...
13.
Bannone E, Cattelani A, Corvino G, Marchetti A, Andreasi V, Fermi F, et al.
Ann Surg
. 2024 Oct;
PMID: 39435540
Objective: To validate the ISGPS definition and grading system of PPAP after pancreatoduodenectomy (PD). Summary Background Data: In 2022, the International Study Group for Pancreatic Surgery (ISGPS) defined post-pancreatectomy acute...
14.
Pecorelli N, Ricci C, Esposito A, Capretti G, Partelli S, Butturini G, et al.
Updates Surg
. 2024 Oct;
77(1):9-17.
PMID: 39397215
Intraperitoneal prophylactic drain (IPD) use in distal pancreatectomy (DP) is still controversial. A survey was carried out through the Italian community of pancreatic surgeons using institutional emails, Twitter, and Facebook...
15.
Vanella G, Leone R, Frigo F, Bronswijk M, van Wanrooij R, Tamburrino D, et al.
DEN Open
. 2024 Oct;
5(1):e70024.
PMID: 39377069
Objectives: Malignant double obstruction, defined as the simultaneous presence of biliary and gastric outlet obstruction, represents a challenging clinical scenario. Previous retrospective experiences have demonstrated shorter dysfunction-free survival (DyFS) of...
16.
Bruna C, van Hilst J, Esposito A, Kleive D, Falconi M, Primrose J, et al.
Br J Surg
. 2024 Sep;
111(9).
PMID: 39287489
No abstract available.
17.
Kirienko M, Gelardi F, Fiz F, Bauckneht M, Ninatti G, Pini C, et al.
Eur J Nucl Med Mol Imaging
. 2024 Sep;
52(1):208-224.
PMID: 39256216
Purpose: For several years, oncological positron emission tomography (PET) has developed beyond 2-deoxy-2-[F]fluoro-D-glucose ([F]FDG). This umbrella review of meta-analyses aims to provide up-to-date, comprehensive, high-level evidence to support appropriate referral...
18.
Ricci C, Pecorelli N, Esposito A, Capretti G, Partelli S, Butturini G, et al.
Updates Surg
. 2024 Sep;
76(6):2501.
PMID: 39225888
No abstract available.
19.
Partelli S, Landoni L, Bartolomei M, Zerbi A, Grana C, Boggi U, et al.
Br J Surg
. 2024 Aug;
111(9).
PMID: 39213395
Background: Resection of non-functioning pancreatic neuroendocrine tumours (NF-PanNETs) is curative in most patients. The potential benefits of neoadjuvant treatments have, however, never been explored. The primary aim of this study...
20.
Tamburrino D, Arcangeli C, De Stefano F, Belfiori G, Macchini M, Orsi G, et al.
Surgery
. 2024 Aug;
176(5):1458-1465.
PMID: 39191599
Background: Pathologic complete response after neoadjuvant treatment in pancreatic ductal adenocarcinoma is a rare occurrence. Similar to other malignancies, achieving a pathologic complete response in pancreatic ductal adenocarcinoma seems to...